Shanghai, China

Chutian Shu

USPTO Granted Patents = 4 

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Pudong District, CN (2022)
  • Shanghai, CN (2021 - 2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Chutian Shu: Innovator in Chemical Synthesis

Introduction

Chutian Shu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of chemical synthesis, holding a total of four patents. His work focuses on innovative methods and compounds that have potential applications in pharmaceuticals.

Latest Patents

Chutian Shu's latest patents include the synthesis of a 1:1:1 co-crystal of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene, L-proline, and water. This patent describes intermediate compounds used to manufacture a crystalline compound known as 1-cyano-2-(4-cyclopropyl-benzyl)-4-(β-D-glucopyranos-1-yl)-benzene L-proline monohydrate. Another notable patent is a chemical process for preparing phenylpiperidinyl indole derivatives. This invention relates to a method of synthesizing a compound of formula (I), which is also referred to as 4-(((2S,4S)-(4-ethoxy-1-(((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof.

Career Highlights

Throughout his career, Chutian Shu has worked with notable companies, including Novartis AG. His expertise in chemical synthesis has allowed him to contribute to various innovative projects and advancements in the pharmaceutical industry.

Collaborations

Chutian Shu has collaborated with esteemed colleagues such as Matthias Eckhardt and Monika Brink. These partnerships have further enhanced his research and development efforts in the field of chemistry.

Conclusion

Chutian Shu is a distinguished inventor whose work in chemical synthesis has led to valuable patents and collaborations. His contributions continue to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…